Risk score of drug-induced liver injury among new tuberculosis patients Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018
Incidence and risk factors for structural lung disease following SARS-CoV-2 infection Source: Virtual Congress 2021 – COVID - 19 risk predictions Year: 2021
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Source: Eur Respir J 2011; 37: 356 Year: 2011
The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 354s Year: 2002
Effect of the risk factors on the characteristics of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Pre-COVID-19 lung function and other risk factors for severe COVID-19 in first responders Source: ERJ Open Res, 7 (1) 00610-2020; 10.1183/23120541.00610-2020 Year: 2021
The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006
Treatment outcome and risk factors of death in elderly patients diagnosed as new cases of tuberculosis Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD). Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
Effect of autoimmune diseases on risk and survival in histology-specific lung cancer Source: Eur Respir J 2012; 40: 1489-1495 Year: 2012
Risk factors for tuberculosis in patients with chronic alcoholism Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
How does current knowledge on primarily hereditary risk factors for asthma and other lung diseases improve prevention, treatment and prognosis? Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine Year: 2012
Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003
Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma Source: Eur Respir J, 58 (6) 2100413; 10.1183/13993003.00413-2021 Year: 2021
Is smoking a major risk factor for COVID-19 infection and severe disease? Source: Virtual Congress 2020 – Smoking, nicotine and COVID-19 myths and facts. What is the evidence? Year: 2020
Effectiveness of treatment and correction of side effects in pulmonary MDR/XDR TB patients with concomitant liver injury Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017
The incidence and risk factors of ventilator associated pneumonia on the mortality in patients with traumatic brain injury Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012
The risk factors in asthma patients for COVID19 infection Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects Year: 2021
Pilot: identification of rehospitalization risk factors for patients with COPD Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital Year: 2005
Factors affecting the duration from diagnosis to treatment in patients with lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 668s Year: 2007